Pacific Biosciences Of California Shares Outstanding 2009-2018 | PACB
Pacific Biosciences Of California shares outstanding history from 2009 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Pacific Biosciences Of California shares outstanding for the quarter ending June 30, 2018 were 0.132B, a 35.46% increase year-over-year.
- Pacific Biosciences Of California 2017 shares outstanding were 0.106B, a 18.55% increase from 2016.
- Pacific Biosciences Of California 2016 shares outstanding were 0.089B, a 17.9% increase from 2015.
- Pacific Biosciences Of California 2015 shares outstanding were 0.076B, a 7.29% increase from 2014.
| Pacific Biosciences Of California Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2017 | 106 |
| 2016 | 89 |
| 2015 | 76 |
| 2014 | 70 |
| 2013 | 63 |
| 2012 | 56 |
| 2011 | 54 |
| 2010 | 10 |
| 2009 | 1 |
| 2008 | 0 |
| 2007 | 0 |
| Pacific Biosciences Of California Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| Q2 2018 | 132 |
| Q1 2018 | 124 |
| Q4 2017 | 106 |
| Q3 2017 | 116 |
| Q2 2017 | 97 |
| Q1 2017 | 93 |
| Q4 2016 | 89 |
| Q3 2016 | 92 |
| Q2 2016 | 88 |
| Q1 2016 | 84 |
| Q4 2015 | 76 |
| Q3 2015 | 80 |
| Q2 2015 | 75 |
| Q1 2015 | 74 |
| Q4 2014 | 70 |
| Q3 2014 | 71 |
| Q2 2014 | 71 |
| Q1 2014 | 68 |
| Q4 2013 | 63 |
| Q3 2013 | 66 |
| Q2 2013 | 62 |
| Q1 2013 | 57 |
| Q4 2012 | 56 |
| Q3 2012 | 56 |
| Q2 2012 | 56 |
| Q1 2012 | 55 |
| Q4 2011 | 54 |
| Q3 2011 | 54 |
| Q2 2011 | 53 |
| Q1 2011 | 53 |
| Q4 2010 | 10 |
| Q3 2010 | 1 |
| Q2 2010 | 1 |
| Q1 2010 | 1 |
| Q4 2009 | 0 |
| Q3 2009 | 1 |
| Q4 2008 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.590B | $0.093B |
| Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.718B | 22.72 |
| Intuitive Surgical (ISRG) | United States | $61.755B | 58.95 |
| Edwards Lifesciences (EW) | United States | $30.784B | 34.67 |
| Fresenius Medical Care (FMS) | Germany | $30.559B | 21.58 |
| IDEXX Laboratories (IDXX) | United States | $19.551B | 59.42 |
| ABIOMED (ABMD) | United States | $17.362B | 142.24 |
| DexCom (DXCM) | United States | $11.769B | 0.00 |
| Teleflex (TFX) | United States | $11.435B | 27.20 |
| Hologic (HOLX) | United States | $11.231B | 19.11 |
| Varian Medical Systems (VAR) | United States | $9.888B | 24.89 |
| STERIS (STE) | United Kingdom | $9.320B | 25.64 |
| Masimo (MASI) | United States | $6.246B | 41.59 |
| LivaNova (LIVN) | United Kingdom | $5.709B | 34.06 |
| Integra LifeSciences Holdings (IART) | United States | $5.388B | 27.88 |
| Globus Medical (GMED) | United States | $5.333B | 35.48 |
| Penumbra (PEN) | United States | $4.900B | 445.44 |
| Inogen (INGN) | United States | $4.526B | 119.76 |
| Cantel Medical (CMD) | United States | $3.666B | 36.93 |
| Wright Medical Group (WMGI) | Netherlands | $3.033B | 0.00 |
| Halyard Health (AVNS) | United States | $2.915B | 23.99 |
| Integer Holdings (ITGR) | United States | $2.479B | 22.44 |
| Glaukos (GKOS) | United States | $2.207B | 0.00 |
| Opko Health (OPK) | United States | $2.166B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.062B | 0.00 |
| Nevro (NVRO) | United States | $1.659B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.526B | 0.00 |
| AxoGen (AXGN) | United States | $1.355B | 0.00 |
| Luminex (LMNX) | United States | $1.254B | 36.97 |
| CryoLife (CRY) | United States | $1.234B | 108.23 |
| Tactile Systems Technology (TCMD) | United States | $1.215B | 207.06 |
| K2Ms (KTWO) | United States | $1.195B | 0.00 |
| Natus Medical (BABY) | United States | $1.110B | 23.55 |
| Orthofix (OFIX) | United States | $1.052B | 32.03 |
| TransEnterix (TRXC) | United States | $1.026B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.920B | 0.00 |
| Intersect ENT (XENT) | United States | $0.901B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.774B | 27.07 |
| ViewRay (VRAY) | United States | $0.709B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.686B | 42.40 |
| Sientra (SIEN) | United States | $0.676B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.432B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Neuronetics (STIM) | United States | $0.425B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.375B | 0.00 |
| Veracyte (VCYT) | United States | $0.375B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.348B | 0.00 |
| Accuray (ARAY) | United States | $0.332B | 0.00 |
| Fluidigm (FLDM) | United States | $0.321B | 0.00 |
| Nuvectra (NVTR) | United States | $0.313B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.300B | 59.25 |
| IRadimed (IRMD) | United States | $0.293B | 105.58 |
| Corindus Vascular Robotics (CVRS) | United States | $0.257B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.251B | 31.45 |
| SeaSpine Holdings (SPNE) | United States | $0.244B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.221B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.205B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.193B | 0.00 |
| Invuity (IVTY) | United States | $0.178B | 0.00 |
| RA MEDICAL SYST (RMED) | United States | $0.138B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.138B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.136B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.130B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.109B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.108B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.076B | 0.00 |
| EDAP TMS (EDAP) | France | $0.075B | 0.00 |
| ConforMIS (CFMS) | United States | $0.060B | 0.00 |
| Electromed (ELMD) | United States | $0.056B | 27.92 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.054B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.053B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.049B | 0.00 |
| Neovasc (NVCN) | Canada | $0.048B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.045B | 0.00 |
| Vermillion (VRML) | United States | $0.043B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.031B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.030B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.029B | 0.00 |
| Dynatronics (DYNT) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.020B | 0.00 |
| Presbia (LENS) | Ireland | $0.020B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.019B | 15.45 |
| Nanovibronix (NAOV) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.014B | 0.00 |
| Avinger (AVGR) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Micron Solutions (MICR) | United States | $0.010B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| InspireMD (NSPR) | Israel | $0.005B | 0.00 |
| Amedica (AMDA) | United States | $0.004B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
